Erratum to: CIP2A mediates prostate cancer progression via the c-MYC signaling pathway

Affiliations

Free article

Published Erratum

Zexiong Guo et al. Tumour Biol. 2015 Aug.

Free article

. 2015 Aug;36(8):6587.

doi: 10.1007/s13277-015-3761-z.

¹ Department of Urology, First Affiliated Hospital of Jinan University, No. 613 West Huangpu Dadao, Guangzhou, 510630, Guangdong, People's Republic of China.

No abstract available

Erratum for

CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z, Liu D, Su Z. Guo Z, et al. Tumour Biol. 2015 May;36(5):3583-9. doi: 10.1007/s13277-014-2995-5. Epub 2015 Jan 6. Tumour Biol. 2015. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 25560487 Retracted.
CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z, Liu D, Su Z. Guo Z, et al. Tumour Biol. 2015 Jun;36(6):4777-83. doi: 10.1007/s13277-015-3129-4. Epub 2015 Jan 31. Tumour Biol. 2015. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 25636449 Retracted.